The ‘Ozempic effect’ hits worldwide share market

Whether health industry or junk food business, steamroller popularity of weight loss drug shakes up stock prices The huge success of the new wave of GLP-1 (glucagon-like peptide-1) receptor agonist drugs such as market leader Ozempic has had a massive and, many argue, completely overblown effect on share prices in the world’s financial markets over